NCT00276393View on ClinicalTrials.gov

Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Type 1 Diabetes
Interventions
DRUG

Basal insulin

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT00276393 - Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes | Biotech Hunter | Biotech Hunter